1.ACE Inhibitors and Losartan in the Managerment of Hypertesion.
Korean Circulation Journal 1998;28(1):5-7
No abstract available.
Angiotensin-Converting Enzyme Inhibitors*
;
Losartan*
2.Angiotensin converting enzyme inhibitors remain the first treatment of choice.
Pyung Chun OH ; Ichiro SAKUMA ; Toshio HAYASHI ; Kwang Kon KOH
The Korean Journal of Internal Medicine 2016;31(2):237-241
No abstract available.
*Angiotensin-Converting Enzyme Inhibitors
;
Humans
3.Angiotensin Converting Enzyme Inhibitors for the.
Journal of the Korean Pediatric Cardiology Society 2001;5(2):115-127
No Abstract available.
Angiotensin-Converting Enzyme Inhibitors*
;
Angiotensins*
;
Peptidyl-Dipeptidase A*
4.Review of role of the angiotensi converting enzyme inhibitors
Journal of Practical Medicine 2000;383(6):22-24
Angiotensin converting enzyme inhibitors have a good effects for patients with primary hypertension and in solving some outcomes of the diseases leading to left ventricular insuffiency. The mechanism of the drugs is to bind zinc ion of angiotension converting enzyme. Therefore, the effect of converting angiotensin I into angiotension II was lost. Angiotension II has effect of the smooth muscle stimulation, aldosterone excretion, hemodynamic change, catecholomine release and glucocorticoid exeretion.
Angiotensin-Converting Enzyme Inhibitors
;
Pharmaceutical Preparations
5.Enzymatic hydrolysis of antler and properties of hydrolysates.
Fan ZHENG ; Renkuan LI ; Huilin WANG ; Junming ZHUANG ; Xiuyun YE
China Journal of Chinese Materia Medica 2010;35(19):2628-2633
Lyophylized antler powder was hydrolyzed by pepsin and trypsin separately and also simultaneously to give hydrolysates with special physical activities. Complete hydrolysis peptides with MW lower than 1 x 10(3) were collected for assay of angiotensin I-converting enzyme (ACE) inhibitory activity, antioxidant activity and proliferative activity toward UMR-106 osteoblast cells. The results of the experiments revealed that all hydrolysates exhibited potent hydroxyl radical scavenging activity with an IC50 value less than 1 mg/ml which was much lower than the value of 5.5 g x L(-1) for vitamin C. The peptic and peptic tryptic hydrolysates demonstrated strong angiotensin I-converting enzyme (ACE) inhibitory activity. The tryptic hydrolysate increased the proliferation of the UMR-106 cells by 73.43%. The results verified the traditional use of antler in bone-strengthening, anti-aging. The exploratory studies on the ACE inhibitory activity of antler hydrolysates indicated that the hydrolysates might be potentially useful in prevention and treatment of hypertension. Further purification of peptides contributing to the antioxidant activity, angiotensin I-converting enzyme-inhibitory activity and proliferative activity toward osteoblasts from antler hydrolysates is warranted.
Angiotensin-Converting Enzyme Inhibitors
;
metabolism
;
Animals
;
Antioxidants
;
metabolism
;
Antlers
;
chemistry
;
metabolism
;
Biphenyl Compounds
;
metabolism
;
Cell Proliferation
;
drug effects
;
Deer
;
Endopeptidases
;
metabolism
;
Free Radical Scavengers
;
Hydrolysis
;
Hypertension
;
chemically induced
;
Pepsin A
;
metabolism
;
Peptides
;
pharmacology
;
Peptidyl-Dipeptidase A
;
metabolism
;
Picrates
;
metabolism
;
Trypsin
;
metabolism
6.Systematic evaluation of efficacy and safety of Songling Xuemaikang Capsules in treatment of essential hypertension.
Gen-Hao FAN ; Zuo-Ying XING ; Meng-Lin LIU ; Yan CHEN ; Yi-Pei AN ; Zhao-Qi CHEN ; Yong-Xia WANG
China Journal of Chinese Materia Medica 2021;46(2):467-477
To evaluate the efficacy and safety of Songling Xuemaikang Capsules combined with conventional Western medicine in the treatment of essential hypertension. PubMed, VIP, CNKI, Wanfang and other databases were retrieved from the establishment of the database to February 2020 for clinical randomized controlled trial(RCT) about Songling Xuemaikang Capsules combined with conventional Western medicine in the treatment of essential hypertension. The literatures were screened out according to the inclusion criteria, and RevMan 5.3 software was used for Meta-analysis. A total of 3 100 patients in 27 RCTs were enrolled. According to Meta-analysis, Songling Xuemaikang Capsules combined with conventional Western medicine could effectively reduce systolic blood pressure(MD=-7.88,95%CI[-9.68,-6.08],P<0.000 01) and diastolic blood pressure(MD=-7.85, 95%CI[-9.07,-6.62], P<0.000 01), triglyceride(MD=-0.46, 95%CI[-0.66,-0.26], P<0.000 01) and total cholesterol(MD=-0.92, 95%CI[-1.49,-0.35], P=0.001), but increase HDL cholesterol(MD=0.51, 95%CI[0.28, 0.73], P<0.000 01), with a better effect than the Western medicine group alone. The results of LDL-C analysis showed that there was no significant difference between the two groups(MD=-0.91, 95%CI[-1.82, 0.01], P=0.05). The subgroup analysis suggested that reduced systolic blood pressure may be related to the use of ARB. There was a close correlation between CCB drugs and the decrease of diastolic blood pressure. In addition, there was no significant difference in the compliance and the incidence of adverse reactions. Clinical application of Songling Xuemaikang Capsules combined with Western medicine in the treatment of patients with essential hypertension has clear efficacy and certain safety. More clinical randomized controlled trials are needed for verification in the future.
Angiotensin Receptor Antagonists
;
Angiotensin-Converting Enzyme Inhibitors
;
Capsules
;
Drugs, Chinese Herbal
;
Essential Hypertension/drug therapy*
;
Humans
7.Construction of pharmacophore model of PARP-1 inhibitor.
Wen-Ting ZHANG ; Hao YAN ; Feng-Chao JIANG
Acta Pharmaceutica Sinica 2007;42(3):279-285
To construct the pharmacophore model of the poly (ADP-ribose) polymerase-1 inhibitor and to investigate the possible inhibitory mechanisms, ten pharmacophore models of PARP-1 inhibitor were established from the training set of thirty-eight PARP-1 inhibitors with conformer analysis and pharmacophore mapping by using the Catalyst software. Based on the mechanism of action and the known structure-activity relationship of PARP-1 inhibitor, an optimal pharmacophore model including two hydrogen-bonding acceptors and two aromatic hydrophobic core was confirmed. The reliability of the optimal pharmacophore model is preferably with RMS = 0.46, Correl = 0.91, Weight = 2.06, and Config = 15.97. This pharmacophore model not only provided some information about the interaction between enzyme and compound, but also showed excellent forecast ability and contributes to design the PARP-1 inhibitors with undiscovered structure.
Computer-Aided Design
;
Drug Design
;
Enzyme Inhibitors
;
chemistry
;
pharmacology
;
Models, Molecular
;
Molecular Structure
;
Poly (ADP-Ribose) Polymerase-1
;
Poly(ADP-ribose) Polymerase Inhibitors
;
Poly(ADP-ribose) Polymerases
;
chemistry
;
Protein Conformation
8.Spontaneous Resolution of Chronic Subdural Hematoma : Close Observation as a Treatment Strategy.
Hyung Chan KIM ; Jung Ho KO ; Dong Soo YOO ; Sang Koo LEE
Journal of Korean Neurosurgical Society 2016;59(6):628-636
OBJECTIVE: Chronic subdural hematoma (cSDH) is common condition in neurosurgical field. It is difficult to select the treatment modality between the surgical method and the conservative method when patients have no or mild symptoms. The purpose of this study is to provide a suggestion that the patients could be cured with conservative treatment modality. METHODS: We enrolled 16 patients who had received conservative treatment for cSDH without special medications which could affect hematoma resolution such as mannitol, steroids, tranexamic acid and angiotensin converting enzyme inhibitors. The patients were classified according to the Markwalder's Grading Scale. RESULTS: Among these 16 patients, 13 (81.3%) patients showed spontaneously resolved cSDH and 3 (18.7%) patients received surgery due to symptom aggravation and growing hematoma. They were categorized into two groups based on whether they were cured with conservative treatment or not. The first group was the spontaneous resolution group. The second group was the progression-surgery group. The mean hematoma volume in the spontaneous resolution group was 43.1 mL. The mean degree of midline shift in the spontaneous resolution group was 5.3 mm. The mean hematoma volume in the progression-surgery group was 62.0 mL. The mean degree of midline shift in the second group was 6 mm. CONCLUSION: We suggest that the treatment modality should be determined according to the patient's symptoms and clinical condition and close observation could be performed in patients who do not have any symptoms or in patients who have mild to moderate headache without neurological deterioration.
Angiotensin-Converting Enzyme Inhibitors
;
Headache
;
Hematoma
;
Hematoma, Subdural, Chronic*
;
Humans
;
Mannitol
;
Methods
;
Steroids
;
Tranexamic Acid
9.Effects of ACEI induced Cough on LV mass in Hypertensive patients and Its Reduction by Antihypertensive Medication.
Sang Hoon NA ; Jun Hee LEE ; Hae Young LEE ; Jun Kyu LEE ; Hyo Soo KIM ; In Ho CHAE ; Dae Won SOHN ; Byoung Hee OH ; Myoung Mook LEE ; Young Bae PARK ; Yun Sik CHOI ; Young Woo LEE
Korean Circulation Journal 2000;30(12):1546-1554
BACKGROUND AND OBJECTIVES: Angiotensin-converting enzyme inhibitors have the effect of regression of left ventricular hypertrophy which has been known as the adverse prognostic factor in the cardiovascular diseases. There are some reports that patients having low ACE activity are prone to have the ACE inhibitorinduced cough. In this study we evaluate the difference of the regression of left ventricular mass according to ACE inhibitor induced cough. MATERIALS AND METHOD: Newly detected hypertensive patients (N=08) from Jan. 1994 to Dec.1997 without cough and other contraindications to ACEI were prospectively prescribed ACEI and followed up for two years whether they have experienced ACE inhibitor induced cough. Cough and non-cough group are analyzed the amount of regression of left ventricular mass by ECG. RESULTS: Left ventricular mass index decreases significantly from 128 38 to 11936 g/m2(deltaLVMI=9+/-22g/m2, p< 0.05), after ACE inhibitors had been used for two years. There is no difference between cough and non-cough group. When subgroup analysis has been done according to sex and the presence of the baseline left ventricular hypertrophy, LVH(+ group and female have the tendency of the larger amount of decreasing of LVMI than LVH(-) group and male respectively [LVH(+:LVH(-)=15+/-26:-3+/-15, M:F=12+/-24:-7+/-19]. After the adjusting of the influence of baseline LVM and sex, the amount of degree of LVMI regresssion in case of the men without baseline LVH is significantly different in cough and non-cough group. LVMI decreases significantly in non-cough group, but not in cough group. CONCLUSION: ACE inhibitors have the effect of the regression of LVMI by ECG. The amount of change of LVMI is greater in female and the patients with baseline LVH. In case of men without LVH, non-cough group has larger amount of decreasing of LVMI than cough group.
Angiotensin-Converting Enzyme Inhibitors
;
Cardiovascular Diseases
;
Cough*
;
Electrocardiography
;
Female
;
Humans
;
Hypertrophy, Left Ventricular
;
Male
;
Prospective Studies
10.Antihypertensive effect and safety of imidapril on the patient with essential hypertension.
Gue Ru HONG ; Jun Ho BAE ; Dae Jin JUN ; Jong Seon PARK ; Dong Gu SHIN ; Young Jo KIM ; Bong Sup SIM
Yeungnam University Journal of Medicine 1999;16(1):69-75
Imidapril(Tanatril(R)), a newly developed ACE inhibitor, has been used to treat hypertension and congestive heart failure. This study was designed to assess the antihypertensive effect and safety of Imidapril(Tanatril(R)) in patient with essential hypertension. 5-10mg of imidapril(Tanatril(R)) was administered once day in 30 patients with essential hypertension and followed up to 8 weeks. We tested the drug's effectiveness, safety, and the incidence of imidapril induced dry coughs. After 8 weeks of treatment with Imidapril, 76.2%(16/21) of patient showed lowered blood pressure and 47.6% showed normal blood pressure. The overall incidence of adverse effects was 33.3%(7/21). and among these adverse effects. dry cough was shown in only 9.5%. Thus, concluded that imidapril(Tanatril(R)) is as safe and effective as other ACE inhibitors. especially with imidapril showing very little incidence of dry cough compared to other ACE inhibitors.
Angiotensin-Converting Enzyme Inhibitors
;
Blood Pressure
;
Cough
;
Heart Failure
;
Humans
;
Hypertension*
;
Incidence